Brain

Kailo Under Review: Best Pain Patch on the Market? Where to Buy Flex Pain Relief Patches

Discover the Breakthrough Wearable Tech That’s Disrupting the Pain Relief Market – Kailo Flex Patch Offers Drug-Free, Fast-Acting Support with…

8 months ago

Neuropathy No More Under Review: Blue Heron Health News’ Nerve Pain Relief Tips Guide

Natural Nerve Pain Relief Guide by Jodi Knapp Offers Holistic, Non-Pharmaceutical Approach to Peripheral Neuropathy—Emphasizing Gut Health, Lifestyle Changes, and…

8 months ago

Eastern Michigan University unveils Way Forward@EMU, empowering youth health leaders with $1M Toyota grant

YPSILANTI, Mich., May 16, 2025 /PRNewswire/ -- Eastern Michigan University is revolutionizing health education for young leaders with the launch…

8 months ago

Brainomix Presents Robust Validation of Its FDA-Cleared e-Lung Technology from its Collaboration with Boehringer Ingelheim

New studies presented at the American Thoracic Society (ATS) Conference this week validate e-Lung as an accurate tool to identify…

8 months ago

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared…

8 months ago

BrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update

Conference call and webcast rescheduled for 8:30 a.m. Eastern Time on Monday, May 19 NEW YORK, May 15, 2025 /PRNewswire/…

8 months ago

ALS NETWORK ANNOUNCES RESEARCH FUNDS AWARDED TO LIVERMORE LAB FOUNDATION

Researchers to Analyze Medication Effects on Development and Progression of ALS and Parkinson's Diseases LOS ANGELES, May 15, 2025 /PRNewswire/…

8 months ago

GrayMatters Health Expands Mental Health Solutions Portfolio with Launch of Prism™ Suite

Innovative Prism™ Platform Now Includes Protocol for Patients with Depression  NEW YORK, May 15, 2025 /PRNewswire/ -- GrayMatters Health (GMH),…

8 months ago

Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays

First-of-its-kind panel includes brain-derived pTau217, pTau181, pTau231, and total tau assays to advance neurodegenerative disease research FREMONT, Calif., May 15,…

8 months ago